CI vs MLAB · P/E 2.4, rev $274.90B vs P/E 81, rev $241.0M
Cigna Corp (CI) versus Mesa Laboratories Inc (MLAB) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Mesa Laboratories Inc (MLAB) is a scientific & technical instruments company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported MLAB revenue for 2025-03-31 was $241.0M. Net income was -$2.0M. Revenue was up 11.5% from 2024-03-31 to 2025-03-31. MLAB currently screens at market cap $538.3M and trailing P/E 80.5.
CI currently screens at market cap $71.62B and trailing P/E 2.4. MLAB currently screens at market cap $538.3M and trailing P/E 80.5.
Not investment advice. Open the CI and MLAB stock pages for the full models.
Not investment advice.